nifekalant hydrochloride has been researched along with Cardiac Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akieda, K; Amino, M; Fujibayashi, D; Fukushima, T; Hashida, T; Higami, S; Inokuchi, S; Kodama, I; Morita, S; Opthof, T; Otsuka, H; Shima, M; Tamura, K; Tanabe, T; Uemura, S; Yoshioka, K | 1 |
| Bando, K; Okamura, H; Ueda, HI | 1 |
| Aizawa, Y; Chinushi, M; Furushima, H; Hirono, T; Hosaka, Y; Komura, S; Sugiura, H; Tanabe, Y; Washizuka, T; Watanabe, H | 1 |
| Kamakura, S; Kawamura, A; Kurita, T; Miyazaki, S; Morii, I; Nonogi, H; Ohashi, J; Shimizu, W; Yasuda, S | 1 |
3 trial(s) available for nifekalant hydrochloride and Cardiac Diseases
| Article | Year |
|---|---|
Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Countershock; Emergency Service, Hospital; Female; Heart Arrest; Heart Diseases; Humans; Male; Middle Aged; Prognosis; Pyrimidinones; Survival Analysis; Treatment Outcome; Ventricular Fibrillation | 2010 |
Comparison of efficacy of sotalol and nifekalant for ventricular tachyarrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Heart Diseases; Humans; Male; Middle Aged; Pyrimidinones; Secondary Prevention; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2006 |
Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidinones; Risk Factors; Treatment Outcome; Ventricular Fibrillation | 2006 |
1 other study(ies) available for nifekalant hydrochloride and Cardiac Diseases
| Article | Year |
|---|---|
Crystals in the heart.
Topics: Adult; Cardiomyopathy, Dilated; Crystallization; Echocardiography, Transesophageal; Female; Heart Diseases; Humans; Infusions, Intravenous; Potassium Channel Blockers; Pyrimidinones; Thrombosis | 2004 |